Blood types information myvmc 1 unit electricity price india

####

The ABO blood groups are made up of 4 types of blood – A, B, AB and O. An individual’s ABO blood type is determined by the hereditary presence or absence of the antigens A and B on the surfaces of RBCs. Antibodies of the ABO group appear in the plasma 2-8 months after birth mainly in response to the bacteria that inhabit the intestines. However, antibodies cross-react with RBC antigens that are different to those present on the individual’s own RBCs. This cross-reaction can be fatal and therefore has great significance in blood transfusions.

People with type A blood have the antigen A on the surface of their RBCs, while people with type B blood have the B antigen. Individuals with type AB blood have both A and B antigens, whereas people with type O blood have no antigens present (there is no antigen O). The antibody that reacts against antigen A is called anti-A, and is found in the plasma of people who do not possess antigen A on their own RBCs – that is, people with type O or type B blood. The antibody that reacts against antigen B is called anti-B and is present in those who do not possess antigen B in their RBCs – people with type O or type A blood.

An antibody can attach to several RBCs at once and bind them together. Agglutination is the clumping of RBCs bound together by antibodies. In giving transfusions, it is very important that the donor’s RBCs not agglutinate as they enter the recipient’s bloodstream.

For example, if type B blood (with B antigens) were transfused into a type A recipient (with anti-B antibodies), the recipient’s anti-B antibodies would immediately agglutinate the donor’s RBCs, causing a transfusion reaction where the agglutinated RBCs block small vessels and release their haemoglobin (Hb) over the next few hours to days. This free Hb can block the kidney tubules and cause death from kidney failure within a day or so. Therefore, a person with type A (anti-B) blood cannot receive B or AB blood, a person with type B (anti-A) blood cannot receive A or AB blood, and a person with type O (anti-A and ant-B) blood cannot receive A, B or AB blood.

The Rhesus or Rh blood group is named after the rhesus monkeys in which they were first discovered. Individuals either belong to the Rh-positive (Rh+) or Rh-negative (Rh-) Rhesus blood group. People with the Rh+ blood group have D antigens on the surface of their red blood cells, while Rh- individuals do not.

In contrast to the ABO group, anti-D antibodies that react against D antigens are not usually present in the blood under normal conditions. They only form in Rh- individuals who are exposed to Rh+ blood. If an Rh- receives an Rh+ transfusion, the recipient produces anti-D antibodies. Since anti-D does not form instantaneously, there is little danger in the first mismatched transfusion. However, because the recipient will now start producing anti-D, a subsequent Rh+ transfusion could agglutinate the donor’s RBCs.

A related condition can occur when a Rh- woman is pregnant with a Rh+ foetus. The first pregnancy is generally uneventful since anti-D does not form right away, so that even if the mother is exposed to Rh+ foetal blood via miscarriage or placental tearing at the time of birth, there is no danger to her first Rh+ child. However, she does begin to produce anti-D antibodies upon her first exposure to Rh+ foetal blood, although this does not occur instantaneously. If she becomes pregnant again with a Rh+ foetus, her anti-D antibodies can pass through the placenta and agglutinate the foetal RBCs. Agglutinated RBCs haemolyse (release their Hb), and the baby is born with a severe anaemia called haemolytic disease of the newborn (HDN), which may kill the infant or leave brain damaged.

HDN is relatively easy to prevent, while very difficult to treat. A Rh- mother is at risk of having a Rh+ baby if the baby’s father is Rh+. As a result, it is now common to give immune globulin at 28-32weeks gestation and at birth to any pregnancy involving a Rh- mother and a Rh+ father. Immune globulin binds foetal RBC antigens so that they cannot stimulate the mother’s immune system to produce anti-D, hence preventing HDN. References